CCCC

C4 Therapeutics, Inc.
Data: 2026-09-04
Quick Stats
Sep 04, 2026

52.3

AI Score

HOLD

0.98

Volume Ratio

TBA

Next Earnings

18

+ve Days (30d)

12

-ve Days (30d)

CCCC Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

CCCC Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

CCCC Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CCCC Daily Out of Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CCCC Daily In the Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CCCC Most Active Options by Volume(near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track
CCCC Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CCCC Stock Summary

Last updated Sep 04, 2026

CCCC is currently trading at $3.76, positioned above its 200-day moving average of $3.04, indicating a long-term uptrend. The stock has a 52-week range of $1.6901 to $5.17.

Technical Analysis: The 50-day moving average stands at $3.91, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.84, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.035, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CCCC at 52.3/100 with a HOLD recommendation.

CCCC (C4 Therapeutics, Inc.) Indicators

Last updated Sep 04, 2026

Indicator Value
RSI(14) 44.84
CMF (20) 0.035
ROC (10) -6.0
ADX (14) 13.547
Indicator Value
MACD (12,26,9) -0.016
AROONOSC (14) -64.286
WILLAMS %R (14) -86.038
MFI (14) 45.666

C4 Therapeutics, Inc. is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

CCCC Moving Averages Analysis

C4 Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 04, 2026

CCCC (C4 Therapeutics, Inc.) Simple Moving Averages

Moving Averages are last updated Sep 04, 2026

Days MA
10 3.94
20 3.99
30 3.86
50 3.91
100 3.69
200 3.04

CCCC Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 457.0 million
Earnings/Share ($) -0.91
Net Profit Margin (%) -2.8944
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.885
EPS Estimate Next Year ($) -0.9975
WallStreet Target Price ($) 13.33
Most Recent Quarter

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.